VANGUARD GROUP INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2024$356,006,766
-12.9%
14,054,748
+6.3%
0.01%
-12.5%
Q1 2024$408,828,136
-20.9%
13,222,126
+3.3%
0.01%
-27.3%
Q4 2023$516,747,868
+73.8%
12,800,294
+13.5%
0.01%
+57.1%
Q3 2023$297,347,619
+47.9%
11,275,981
-3.5%
0.01%
+40.0%
Q2 2023$200,981,949
+0.5%
11,684,997
-3.1%
0.01%0.0%
Q1 2023$200,008,785
+147.8%
12,063,256
+13.9%
0.01%
+150.0%
Q4 2022$80,706,888
-18.8%
10,591,455
+5.9%
0.00%
-33.3%
Q3 2022$99,442,000
+10.7%
10,004,271
+1.1%
0.00%0.0%
Q2 2022$89,851,000
-6.1%
9,895,537
+5.0%
0.00%
+50.0%
Q1 2022$95,655,000
-38.5%
9,424,112
+1.0%
0.00%
-50.0%
Q4 2021$155,653,000
-64.8%
9,331,683
-1.1%
0.00%
-63.6%
Q3 2021$442,238,000
-36.0%
9,435,412
-16.7%
0.01%
-35.3%
Q2 2021$690,623,000
+20.0%
11,329,129
+21.3%
0.02%
+6.2%
Q1 2021$575,417,000
+25.6%
9,341,186
+45.0%
0.02%
+23.1%
Q4 2020$458,042,000
+93.9%
6,441,312
+2.3%
0.01%
+62.5%
Q3 2020$236,193,000
+25.2%
6,295,118
+8.8%
0.01%
+14.3%
Q2 2020$188,698,000
+174.6%
5,786,518
+144.2%
0.01%
+133.3%
Q1 2020$68,705,000
-8.4%
2,369,131
+10.7%
0.00%0.0%
Q4 2019$75,042,000
+119.4%
2,140,996
+34.4%
0.00%
+200.0%
Q3 2019$34,201,000
+1352.9%
1,592,950
+1725.1%
0.00%
Q2 2019$2,354,00087,2820.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$60,317,00040.05%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$308,746,0006.20%
M28 Capital Management LP 513,300$5,102,0005.33%
GREAT POINT PARTNERS LLC 1,050,000$10,437,0002.51%
Octagon Capital Advisors LP 933,743$9,281,0001.60%
HHLR ADVISORS, LTD. 5,362,014$53,298,0001.40%
VIKING GLOBAL INVESTORS LP 26,620,991$264,613,0001.22%
Cormorant Asset Management, LP 1,469,179$14,604,0001.02%
Fernwood Investment Management, LLC 204,550$2,033,0000.86%
TANG CAPITAL MANAGEMENT LLC 585,424$5,819,0000.71%
View complete list of BRIDGEBIO PHARMA INC shareholders